AGER and autoimmune hepatitis: Furthermore, EN-RAGE, sRAGE and EN-RAGE/sRAGE yielded AUC of 0.82 (95% CI, 0.75–0.92), 0.69 (95% CI, 0.56–0.82) and 0.83 (95% CI, 0.73–0.93) for identifying AIH patients with therapeutic response versus treatment-naïve AIH patients (Fig. 5d), and EN-RAGE/sRAGE with highest AUC generated 76.1% sensitivity, 81% specificity with cutoff value 36.65, suggesting that identified EN-RAGE/sRAGE also has potential predicting power for the remission of AIH patients.